ImmunityBio (IBRX) Other Non-Current Liabilities (2014 - 2026)
ImmunityBio (IBRX) reported Other Non-Current Liabilities of $352.38 million for Q2 2026, up 426.3% from $66.96 million a year earlier and up 14.3% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio posted Other Non-Current Liabilities of $84.42 million, up 223.2% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 141.2% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $26.12 million in FY2024 (-78.0%), $118.77 million in FY2023 (+448.9%), $21.64 million in FY2022 and $411,000 in FY2021 (-60.3%).
- The Q2 2026 figure ranks as the highest quarterly Other Non-Current Liabilities in data going back to Q4 2014.
- Year over year, Other Non-Current Liabilities gained in four of the last seven quarters, with growth averaging 134.3%.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q1 2024 (growth of 518.6%); the low point was Q1 2025 (a decline of 81.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $308.19 million (Q1 2026), $84.42 million (Q4 2025) and $115.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | ImmunityBio | 9.30 Bn | 8.06 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 352.38 Mn |
| Mar 31, 2026 | 308.19 Mn |
| Dec 31, 2025 | 84.42 Mn |
| Sep 30, 2025 | 115.16 Mn |
| Jun 30, 2025 | 66.96 Mn |
| Mar 31, 2025 | 20.54 Mn |
| Dec 31, 2024 | 26.12 Mn |
| Sep 30, 2024 | 19.22 Mn |
| Jun 30, 2024 | 65.40 Mn |
| Mar 31, 2024 | 109.99 Mn |
| Dec 31, 2023 | 118.77 Mn |
| Sep 30, 2023 | 39.37 Mn |
| Jun 30, 2023 | 27.80 Mn |
| Mar 31, 2023 | 17.78 Mn |
| Dec 31, 2022 | 21.64 Mn |
| Sep 30, 2022 | 569,000.00 |
| Jun 30, 2022 | 290,000.00 |
| Mar 31, 2022 | 288,000.00 |
| Dec 31, 2021 | 411,000.00 |
| Sep 30, 2021 | 905,000.00 |
API Access
ImmunityBio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();